Bextra Off-label Promotion Scheme Earns Pfizer Largest Fine in History
While most pharma-watchers have been reading Wyeth tea leaves, the company yesterday announced, almost as an aside, that it had settled a $2.3 billion fine for off-label promotion of Bextra. This dwarfs the recent Lilly/Zyprexa off-label fine, as it also does the liability Pfizer inherited from Warner-Lambert over off-label Neurontin promotion.
So what did Pfizer do to become #1 in off-label fines? For now, it appears that most of the details remain uncertain. However, our crack investigative team (Lil, Duane, and Suzette) noticed that Pfizer had earlier settled an off-label and otherwise illicit promotion charge over Celebrex and Bextra with the state of Alaska. A report of that settlement is below.
Same stuff? Lil, Duane, and Suzette can't confirm it. But at least we now know who won the Superbowl. So you are free to spend the weekend on other things.